Prevalence of Betalactamase Producing and Multidrug Resistance Index of Enterobacteriacea from a Tertiary Hospital in Kaduna Nigeria


Authors : Adejo Peter O; Ajibade G. A; Muhamed Jamiu A.

Volume/Issue : Volume 6 - 2021, Issue 11 - November

Google Scholar : http://bitly.ws/gu88

Scribd : https://bit.ly/3m6ulOu

In the last two decades, increase in multidrug resistance (MDR) of nosocomial bacterial has become a major health challenge worldwide. Enterobacteriaceae are significant causes of serious infections, and many of the clinical important members of this family are becoming increasingly resistant to currently available antibiotics. In this study, one hundred and thirteen nonrepeated multidrug resistant enterobacteriaceae were collected from a tertiary hospital for the study and screened for betalactamase production using penicillinphenol red reagent. E. coli (38), K. Pneumonae (20), Shigellasp (24) and Salmonella sp (31) were the organisms of interest. Results showed the isolates had a MARI of 0.6 and 48.67% of isolates were betalactamase producers. Isolates were observed to be resistant to various antibiotics with Augmentin having the highest mean resistance rate of 0.98, Ampiclox 0.84, Perfloxacillin 0.82, Erythromycin 0.81, Zinacef 0.79, Amoxicillin and Ofloxacillin 0.77, Septrin and Rocephin 0.75, Chloramphenicol 0.67, Ciprofloxacillin 0.59, Gentamycin 0.56 and streptomycin 0.44. Multi drug resistance in isolates were very high with isolates been resistant to at least six antibiotics and this is linked with the production of betalactamase which render betalactam antibiotics infective. There is need for closer monitoring of drug resistant trends and betalactamase production in both clinical and community settings. This will go a long way in reducing the spread of antibiotic resistance.

CALL FOR PAPERS


Paper Submission Last Date
31 - May - 2022

Paper Review Notification
In 1-2 Days

Paper Publishing
In 2-3 Days

Never miss an update from Papermashup

Get notified about the latest tutorials and downloads.

Subscribe by Email

Get alerts directly into your inbox after each post and stay updated.
Subscribe
OR

Subscribe by RSS

Add our RSS to your feedreader to get regular updates from us.
Subscribe